You are here: Industry Insights > API

News List

The Rapidly Expanding Global Weight Loss Market and the Role of Chinese Innovations PharmaSources/ChatGPT
August 28, 2024
The trend highlights China’s growing influence in the global pharmaceutical landscape and its increasing role in advancing global health solutions.
SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases Biotech Newswire
July 09, 2024
The upsized and oversubscribed Series A financing round will be used to drive the lead development program toward clinical proof-of-concept and to broaden the therapeutic value of the proprietary iRhom2 strategy.
Gut Hormone-Based Pharmacotherapies for Obesity Neeta Ratanghayra
April 28, 2024
The history of pharmacotherapy for obesity is marked by a series of promising drugs that were withdrawn due to safety concerns.
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study PharmaSources
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
ARCH Top-tier Pharmaceutical Venture Capital Firm: ARCH Yefenghong
March 06, 2024
The R&D of new drugs is inextricably linked to substantial financial backing. Within this framework, the role of venture capital firms is immeasurable. Today, we spotlight the renowned venture capital entity, ARCH.
The Evolving Landscape of Heart Failure Therapies Neeta Ratanghayra
January 31, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.
Regulatory Compliance in API Drug Production of Different Countries PharmaSources
January 02, 2024
Active pharmaceutical ingredients, also known as APIs, refer to the biologically active components of drugs that provide pharmacological activity or direct action.
What's happening in HF therapies Neeta Ratanghayra
January 02, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.The severity of the disease warrants the development of innovative solutions to address the current treatment gap.
The Ultimate Guide to API Pharmaceuticals PharmaSources
November 17, 2023
Active Pharmaceutical Ingredients, are the backbone of medicinal therapy and healthcare interventions. These potent substances are designed to tackle various health challenges, ranging from infectious diseases to chronic ailments and pain relief.
Drying Machines for API (Active Pharmaceutical Ingredient): Types and Applications PharmaSources
November 17, 2023
A drying machine for APIs (Active Pharmaceutical Ingredients) refers to equipment designed to remove moisture from Active Pharmaceutical ingredients during pharmaceutical manufacturing.